BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

116 related articles for article (PubMed ID: 275533)

  • 1. Blastic transformation in chronic myelogenous leukemia: experience with 50 patients.
    Marks SM; McCaffrey R; Rosenthal DS; Moloney WC
    Med Pediatr Oncol; 1978; 4(2):159-67. PubMed ID: 275533
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Clinical utility of terminal deoxynucleotidyl transferase and adenosine deaminase determinations in adult leukemia with a lymphoid phenotype.
    Brusamolino E; Isernia P; Lazzarino M; Scovassi I; Bertazzoni U; Bernasconi C
    J Clin Oncol; 1984 Aug; 2(8):871-80. PubMed ID: 6589363
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Use of terminal deoxynucleotidyl transferase in the diagnosis of leukemia.
    Morse EE; Gaffney J; Donskoy E; Pisciotto P; Altman A; Quinn J; Goldschneider I
    Ann Clin Lab Sci; 1983; 13(2):128-32. PubMed ID: 6344744
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Comparison of the expression of terminal deoxynucleotidyl transferase and common acute lymphoblastic leukemia antigen in selected hematologic malignancies.
    Bodner SM; Casavant CH; McHugh TM; Stites DP
    Diagn Immunol; 1985; 3(3):139-44. PubMed ID: 2932276
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Blast crisis as an initial or terminal manifestation of chronic myeloid leukemia. A study of 28 patients.
    Peterson LC; Bloomfield CD; Brunning RD
    Am J Med; 1976 Feb; 60(2):209-20. PubMed ID: 1062162
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Terminal-deoxynucleotidyl transferase (TdT): serial observations on patients with leukemia.
    Schumacher HR; Haider Y; Miller WM; Stass SA; Bollum FJ
    Am J Med Sci; 1983; 286(3):18-24. PubMed ID: 6356915
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Terminal transferase as a predictor of initial responsiveness to vincristine and prednisone in blastic chronic myelogenous leukemia: a co-operative study.
    Marks SM; Baltimore D; McCaffrey R
    N Engl J Med; 1978 Apr; 298(15):812-4. PubMed ID: 273142
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Differential analysis of BM cell morphology, immunophenotypic, cytogenetic characters and prognosis between myeloblastic and lymphoblastic crisis of CML].
    Liu YL; Wang XN; Liu HS
    Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2014 Jun; 22(3):629-33. PubMed ID: 24989266
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Terminal deoxynucleotidyl transferase activity in human leukemic cells and in normal human thymocytes.
    McCaffrey R; Harrison TA; Parkman R; Baltimore D
    N Engl J Med; 1975 Apr; 292(15):775-80. PubMed ID: 1054106
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Terminal deoxynucleotidyl transferase measurements in the differential diagnosis of adult leukaemias.
    Hutton JJ; Coleman MS
    Br J Haematol; 1976 Nov; 34(3):447-56. PubMed ID: 62584
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Myeloblastic and lymphoblastic markers in acute undifferentiated leukemia and chronic myelogenous leukemia in blast crisis.
    Shumak KH; Baker MA; Taub RN; Coleman MS
    Cancer Res; 1980 Nov; 40(11):4048-52. PubMed ID: 6937237
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Diagnostic and prognostic value of the terminal deoxynucleotidyl transferase (TdT) activity in treating the blastic phase (bp) of chronic granulocytic leukaemia (CGL).
    Rudzka E; Hołowiecki J; Bartnikowa W; Krawczyk M; Duraj M; Jarczok K; Hołowiecka B; Suhs M
    Folia Haematol Int Mag Klin Morphol Blutforsch; 1985; 112(6):864-71. PubMed ID: 2419215
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Terminal-deoxynucleotidyl-transferase immunofluorescence on bone marrow smears: serial studies on 28 patients.
    Miller WM; Stass SA; Schumacher HR; Bollum FJ
    Am J Hematol; 1981; 10(1):1-7. PubMed ID: 7020412
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Philadelphia chromosome and terminal transferase-positive acute leukemia: similarity of terminal phase of chronic myelogenous leukemia and de novo acute presentation.
    Jain K; Arlin Z; Mertelsmann R; Gee T; Kempin S; Koziner B; Middleton A; Jhanwar S; Chaganti R; Clarkson B
    J Clin Oncol; 1983 Nov; 1(11):669-76. PubMed ID: 6366129
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Mitoxantrone, vincristine, and prednisone in adults with relapsed or primarily refractory acute lymphocytic leukemia and terminal deoxynucleotidyl transferase positive blastic phase chronic myelocytic leukemia.
    Paciucci PA; Keaveney C; Cuttner J; Holland JF
    Cancer Res; 1987 Oct; 47(19):5234-7. PubMed ID: 3476201
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Chronic myelogenous leukemia presenting in blastic crisis.
    Bornstein RS; Nesbit M; Kennedy BJ
    Cancer; 1972 Oct; 30(4):939-41. PubMed ID: 4507469
    [No Abstract]   [Full Text] [Related]  

  • 17. Clinical utility of leukemia cell terminal transferase measurements.
    McCaffrey R; Lillquist A; Sallan S; Cohen E; Osband M
    Cancer Res; 1981 Nov; 41(11 Pt 2):4814-20. PubMed ID: 7028251
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Characteristics of the blastic crisis with terminal deoxynucleotidyl transferase positive blasts in chronic granulocytic leukemia.
    Sawada H; Tashima M; Konishi H; Usui T; Kita K; Oguma S; Kamada N; Uchino H
    Nihon Ketsueki Gakkai Zasshi; 1981 Jul; 44(4):872-80. PubMed ID: 6949433
    [No Abstract]   [Full Text] [Related]  

  • 19. [Significance of terminal deoxynucleotidyl transferase in lymphoproliferative diseases].
    Telek B; Ember I; Kiss A; Pecze K
    Orv Hetil; 1986 Dec; 127(52):3183-6. PubMed ID: 3468473
    [No Abstract]   [Full Text] [Related]  

  • 20. Terminal deoxynucleotidyl transferase-positive acute myeloblastic leukemia.
    McGraw TP; Folds JD; Bollum FJ; Stass SA
    Am J Hematol; 1981; 10(3):251-8. PubMed ID: 6264782
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.